Metraipolis › archive › dc_4acbc0b60cb7

Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy — Europe PMC PMID:41428405

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41428405
DOI: 10.2215/cjn.0000000961
License (as archived): solo-consultazione
Archived: 2026-11-07T11:42:26.272Z
SHA-256 of the archived text: 813d0905f08719cb396f9b1d6a3de76b2640d378246d67d3b154201a2f181d8d
Stable URL of this page: https://metraipolis.com/documento/dc_4acbc0b60cb7

How to cite

Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy — Europe PMC PMID:41428405 — Europe PMC (en), https://europepmc.org/article/MED/41428405 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_4acbc0b60cb7 (Metraipolis archive dc_4acbc0b60cb7, sha256 813d0905f08719cb396f9b1d6a3de76b2640d378246d67d3b154201a2f181d8d)

BibTeX

@misc{dc4acbc0b60cb7,
  title = {Association between Complete Proteinuria Remission and Kidney Function in the Phase 3 PROTECT Trial of Sparsentan in IgA Nephropathy — Europe PMC PMID:41428405},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41428405},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_4acbc0b60cb7; sha256 813d0905f08719cb396f9b1d6a3de76b2640d378246d67d3b154201a2f181d8d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41428405. Agents can read the archived copy with the MCP tool read_document.